Sage Journals: Discover world-class research

Abstract

Chlamydia trachomatis infections, which most frequently are asymptomatic, are major public health concerns globally. The 2015 European C. trachomatis guideline provides: up-to-date guidance regarding broader indications for testing and treatment of C. trachomatis infections; a clearer recommendation of using exclusively-validated nucleic acid amplification tests for diagnosis; advice on (repeated) C. trachomatis testing; the recommendation of increased testing to reduce the incidence of pelvic inflammatory disease and prevent exposure to infection; and recommendations to identify, verify and report C. trachomatis variants. Improvement of access to testing, test performance, diagnostics, antimicrobial treatment and follow-up of C. trachomatis patients are crucial to control its spread. For detailed background, evidence base and discussions, see the background review for the present 2015 European guideline on the management of Chlamydia trachomatis infections (Lanjouw E, et al. Int J STD AIDS. 2015).

Keywords

genital sexually transmitted infection lymphogranuloma venereum pelvic inflammatory disease Europe diagnosis treatment antibiotic

Get full access to this article

View all access options for this article.

References

Stamm

Chlamydia trachomatis infections of the adults. In: Holmes

Sparling

et al. (eds). Sexually transmitted diseases, 4th ed. New York, NY: McGraw Hill, 2008. chap. 32.

Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2010. http://www.cdc.gov/std/stats11/surv2011.pdf (2011, accessed 15 August 2015).

European Centre for Disease Prevention and Control. Chlamydia control in Europe: literature review, http://www.ecdc.europa.eu/en/publications/Publications/chlamydia-control-europe.pdf (2014, accessed 15 August 2015).

European Centre for Disease Prevention and Control. Sexually transmitted infections in Europe 2013. http://www.ecdc.europa.eu/en/publications/Publications/sexually-transmitted-infections-europe-surveillance-report-2013.pdf (2015, accessed 15 August 2015).

Dielissen

Teunissen

DAM

Lagro-Janssen

ALM

. Chlamydia prevalence in the general population: Is there a sex difference? A systematic review. BMC Infect Dis 2013; 13: 534. .

Redmond

Alexander-Kisslig

Woodhall

et al.

Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis. PLoS One 2015; 10: e0115753.

Mitchell

White

Rahimi

et al.

Predictors of gonorrhea and chlamydia in emergency department patients. Ann Emerg Med 2012; 60: S119.

Althaus

Heijne

Low

. Towards more robust estimates of the transmissibility of Chlamydia trachomatis. Sex Transm Dis 2012; 39: 402–404.

Quinn

Gaydos

Shepherd

et al.

Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276: 1737–1742.

10.

Everett

Bush

Andersen

. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999; 49: 415–440.

11.

Sachse

Bavoil

Kaltenboeck

et al.

Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to include all currently recognized species. Syst Appl Microbiol 2015; 38: 99–103.

12.

Molano

Meijer

Weiderpass

et al.

The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 2005; 191: 907–916.

13.

Morre

van den Brule

Rozendaal

et al.

The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002; 13: 12–18.

14.

Bevan

Johal

Mumtaz

et al.

Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol 1995; 102: 407–414.

15.

Morcos

Frost

Hnat

et al.

Laparoscopic versus clinical diagnosis of acute pelvic inflammatory disease. J Reprod Med 1993; 38: 53–56.

16.

Recommendations arising from the 31st Study Group: The Prevention of Pelvic Infection. London; RCOG Press, 1996, pp. 267–270.

17.

Kent

Chaw

Wong

et al.

Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005; 41: 67–74.

18.

Boisvert

Koutsky

Suchland

et al.

Clinical features of Chlamydia trachomatis rectal infection by serovar among homosexually active men. Sex Transm Dis 1999; 26: 392–398.

19.

Quinn

Goodell

Mkrtichian

et al.

Chlamydia trachomatis proctitis. New Engl J Med 1981; 305: 195–200.

20.

Marcus

Bernstein

Stephens

et al.

Sentinel surveillance of rectal chlamydia and gonorrhea among males – San Francisco, 2005–2008. Sex Transm Dis 2010; 37: 59–61.

21.

Pinsky

Chiarilli

Klausner

et al.

Rates of asymptomatic nonurethral gonorrhea and chlamydia in a population of university men who have sex with men. J Am Coll Health 2012; 60: 481–484.

22.

Van Liere

GAFS

Hoebe

CJPA

Dukers-Muijrers

NHTM

. Evaluation of the anatomical site distribution of chlamydia and gonorrhoea in men who have sex with men and in high-risk women by routine testing: Cross-sectional study revealing missed opportunities for treatment strategies. Sex Transm Infect 2014; 90: 58–60.

23.

van Liere

Hoebe

Wolffs

et al.

High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study; a recommendation towards a better anorectal chlamydia control in women. BMC Infect Dis 2014; 14: 274.

24.

van Rooijen

Schim van der Loeff

Morre

et al.

Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands. Sex Transm Infect 2015; 91: 157–164.

25.

Park

Marcus

Pandori

et al.

Sentinel surveillance for pharyngeal chlamydia and gonorrhea among men who have sex with men – San Francisco, 2010. Sex Transm Dis 2012; 39: 482–484.

26.

Barbee

Dombrowski

Kerani

et al.

Effect of nucleic acid amplification testing on detection of extragenital gonorrhea and chlamydial infections in men who have sex with men sexually transmitted disease clinic patients. Sex Transm Dis 2014; 41: 168–172.

27.

Jones

Al-Hussaini

Dunlop

. Infection of the eye and the genital tract by Tric agent. Br J Vener Dis 1964; 40: 19–24.

28.

Harding-Esch

Burton

et al.

Epidemiology and control of trachoma: Systematic review. Trop Med Int Health 2010; 15: 673–691.

29.

Darville

. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis 2005; 16: 235–244.

30.

Hammerschlag

. Chlamydial infections. J Pediatr 1989; 114: 727–734.

31.

Martin-Iguacel

Llibre

Nielsen

et al.

Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries. Eur J Clin Microbiol Infect Dis 2010; 29: 917–925.

32.

Nieuwenhuis

Ossewaarde

Götz

et al.

Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar L2 proctitis in The Netherlands among men who have with men. Clin Infect Dis 2004; 39: 996–1003.

33.

Ahdoot

Kotler

Suh

et al.

Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York City. J Clin Gastroenterol 2006; 40: 385–390.

34.

Jebbari

Alexander

Ward

et al.

Update on lymphogranuloma venereum in the United Kingdom. Sex Transm Infect 2007; 83: 324–326.

35.

van de Laar

. The emergence of LGV in Western Europe: what do we know, what can we do? Euro Surveill 2006; 11: 146–148.

36.

White

. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis 2009; 22: 57–66.

37.

Hoie

Knudsen

Gerstoft

. Lymphogranuloma venereum proctitis: a differential diagnose to inflammatory bowel disease. Scand J Gastroenterol 2011; 46: 503–510.

38.

Lanjouw

van Daele

Raes

et al.

Consecutively acquired sexually transmitted infections mimicking Crohn's disease. Am J Gastroenterol 2009; 104: 532–533.

39.

de Vrieze

van Rooijen

Schim van der Loeff

et al.

Anorectal and inguinal lymphogranuloma venereum among men who have sex with men in Amsterdam, The Netherlands: trends over time, symptomatology and concurrent infections. Sex Transm Infect 2013; 89: 548–552.

40.

de Vries

Zingoni

Kreuter

et al.

2013 European guideline on the management of lymphogranuloma venereum. J Eur Acad Dermatol Venereol 2015; 29: 1–6.

41.

Stamm

Guinan

Johnson

et al.

Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. New Engl J Med 1984; 310: 545–549.

42.

Rees

. The treatment of pelvic inflammatory disease. Am J Obstet Gynecol 1980; 138: 1042–1047.

43.

Rekart

Gilbert

Meza

et al.

Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis 2013; 207: 30–38.

44.

Bender

Herrmann

Andersen

et al.

Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Sex Transm Infect 2011; 87: 601–608.

45.

French

Hughes

Nicholson

et al.

Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000-2008. Sex Transm Dis 2011; 38: 158–162.

46.

Bjartling

Osser

Persson

. The frequency of salpingitis and ectopic pregnancy as epidemiologic markers of Chlamydia trachomatis. Acta Obstet Gynecol Scand 2000; 79: 123–128.

47.

Adams

Turner

KME

Edmunds

. The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect 2007; 83: 267–274. discussion 274–275.

48.

van Valkengoed

Morre

van den Brule

et al.

Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes – implications for cost-effectiveness analyses. Int J Epidemiol 2004; 33: 416–425.

49.

Land

Van Bergen

JEAM

Morre

et al.

Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update 2010; 16: 189–204.

50.

Oakeshott

Kerry

Aghaizu

. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010; 340: c1642.

51.

Kavanagh

Wallace

Robertson

et al.

Estimation of the risk of tubal factor infertility associated with genital chlamydial infection in women: a statistical modelling study. Int J Epidemiol 2013; 42: 493–503.

52.

Trent

Bass

Ness

et al.

Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis 2011; 38: 879–881.

53.

Westrom

Joesoef

Reynolds

et al.

Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19: 185–192.

54.

Chow

Yonekura

Richwald

et al.

The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study. JAMA 1990; 263: 3164–3167.

55.

Miettinen

Heinonen

Teisala

et al.

Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy. Sex Transm Dis 1990; 17: 10–14.

56.

Ness

Trautmann

Richter

et al.

Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 2005; 106: 573–580.

57.

Ross

Judlin

Jensen

. 2012 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2014; 25: 1–7.

58.

US Centers for Disease Control and Prevention. Male chlamydia screening consultation Atlanta, Georgia, 28–29 March 2006, http://www.cdc.gov/std/chlamydia/chlamydiascreening-males.pdf (2007, accessed 15 August 2015).

59.

Bezold

Politch

Kiviat

et al.

Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril 2007; 87: 1087–1097.

60.

Greendale

Haas

Holbrook

et al.

The relationship of Chlamydia trachomatis infection and male infertility. Am J Public Health 1993; 83: 996–1001.

61.

Joki-Korpela

Sahrakorpi

Halttunen

et al.

The role of Chlamydia trachomatis infection in male infertility. Fertil Steril 2009; 91: 1448–1450.

62.

Carter

Hudson

. The evolving story of Chlamydia-induced reactive arthritis. Curr Opin Rheumatol 2010; 22: 424–430.

63.

Taylor-Robinson

Keat

. Observations on Chlamydia trachomatis and other microbes in reactive arthritis. Int J STD AIDS 2015; 26: 139–144.

64.

Bojovic

Strelic

Pavlica

. Reiter's syndrome – disease of young men – analysis of 312 patients. Med Pregl 2014; 67: 222–230.

65.

Carlin

Ziza

Keat

et al.

2014 European Guideline on the management of sexually acquired reactive arthritis. Int J STD AIDS 2014; 25: 901–912.

66.

Cook

Hutchison

Ostergaard

et al.

Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142: 914–925.

67.

Watson

Templeton

Russell

et al.

The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002; 51: 1021–1031.

68.

Skidmore

Horner

Mallinson

. Testing specimens for Chlamydia trachomatis. Sex Transm Infect 2006; 82: 272–275.

69.

Skidmore

Horner

Herring

et al.

Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting?

J Clin Microbiol 2006; 44: 4389–4394.

70.

Choe

Lee

et al.

Performance of Anyplex II multiplex real-time PCR for the diagnosis of seven sexually transmitted infections: comparison with currently available methods. Int J Infect Dis 2013; 17: e1134–e1140.

71.

Gimenes

Medina

Abreu

et al.

Sensitive simultaneous detection of seven sexually transmitted agents in semen by multiplex-PCR and of HPV by single PCR. PLoS One 2014; 9: e98862.

72.

Kumamoto

Matsumoto

Fujisawa

et al.

Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urogenital and oral specimens using the Cobas^R 4800, APTIMA Combo 2^R TMA, and ProbeTec ET SDA assays. Eur J Microbiol Immunol (Bp) 2012; 2: 121–127.

73.

Le Roy

Le Hen

Clerc

et al.

The first performance report for the Bio-Rad Dx CT/NG/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples. J Microbiol Meth 2012; 89: 193–197.

74.

Mushanski

Brandt

Coffin

et al.

Comparison of the BD viper system with XTR technology to the Gen-Probe APTIMA COMBO 2 assay using the TIGRIS DTS system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens. Sex Transm Dis 2012; 39: 514–517.

75.

Schachter

Chow

Howard

et al.

Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised. J Clin Microbiol 2006; 44: 2512–2517.

76.

van der Helm

Hoebe

van Rooijen

et al.

High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women. Sex Transm Dis 2009; 36: 493–497.

77.

Cheng

Qian

Kirby

. Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cobas Amplicor CT/NG assay. J Clin Microbiol 2011; 49: 1294–1300.

78.

Workowski

Bolan

. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64: 1–137.

79.

Unemo

Rossouw

James

et al.

Can the Swedish new variant of Chlamydia trachomatis (nvCT) be detected by UK NEQAS participants from seventeen European countries and five additional countries/regions in 2009?

Euro Surveill 2009; 14: pii: 19206. .

80.

Reischl

Straube

Unemo

. The Swedish new variant of Chlamydia trachomatis (nvCT) remains undetected by many European laboratories as revealed in the recent PCR/NAT ring trial organised by INSTAND e.V., Germany. Euro Surveill 2009; 14: pii: 19302. .

81.

Shipitsyna

Zolotoverkhaya

Agne-Stadling

et al.

First evaluation of six nucleic acid amplification tests widely used in the diagnosis of Chlamydia trachomatis in Russia. J Eur Acad Dermatol Venereol 2009; 23: 268–276.

82.

Ripa

Nilsson

. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill 2006; 11: E061109 2.

83.

Unemo

Seth-Smith

Cutcliffe

et al.

The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization. Microbiology 2010; 156: 1394–1404.

84.

Unemo

Clarke

. The Swedish new variant of Chlamydia trachomatis. Curr Opin Infect Dis 2011; 24: 62–69.

85.

Van Dommelen

Van Tiel

Ouburg

et al.

Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Clin Microbiol Infect 2010; 16: S560.

86.

van der Helm

Sabajo

Grunberg

et al.

Point-of-care test for detection of urogenital chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname. PLoS One 2012; 7: e32122.

87.

Libbus

. Chlamydia Rapid Test was moderately accurate for diagnosing Chlamydia infection in women. Evid Based Nurs 2008; 11: 89.

88.

Hislop

Quayyum

Flett

et al.

Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men Review. Health Technol Assess 2010; 14: 1–97. (iii–iv).

89.

Skidmore

. Poorly performing point-of-care tests for chlamydia: What can be done? Sex Transm Infect 2010; 86: 330.

90.

Mahilum-Tapay

Laitila

Wawrzyniak

et al.

New point of care Chlamydia Rapid Test -- bridging the gap between diagnosis and treatment: performance evaluation study. BMJ 2007; 335: 1190–1194.

91.

Nadala

Goh

Magbanua

et al.

Performance evaluation of a new rapid urine test for chlamydia in men: prospective cohort study. BMJ 2009; 339: b2655.

92.

Huang

Gaydos

Barnes

et al.

Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting. Sex Transm Infect 2013; 89: 108–114.

93.

Gaydos

Van Der Pol

Jett-Goheen

et al.

Performance of the Cepheid CT/NG Xpert Rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2013; 51: 1666–1672.

94.

Wisniewski

White

Michel

et al.

Optimal method of collection of first-void urine for diagnosis of Chlamydia trachomatis infection in men. J Clin Microbiol 2008; 46: 1466–1469.

95.

Mangin

Murdoch

Wells

et al.

Chlamydia trachomatis testing sensitivity in midstream compared with first-void urine specimens. Ann Fam Med 2012; 10: 50–53.

96.

Michel

Sonnex

Carne

et al.

Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol 2007; 45: 1395–1402.

97.

Jang

Gilchrist

et al.

Comparison of flocked and Aptima swabs and two specimen transport media in the Aptima Combo 2 assay. J Clin Microbiol 2014; 52: 3808–3809.

98.

Bialasiewicz

Whiley

Buhrer-Skinner

et al.

A novel gel-based method for self-collection and ambient temperature postal transport of urine for PCR detection of Chlamydia trachomatis. Sex Transm Infect 2009; 85: 102–105.

99.

Graseck

Shih

Peipert

. Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2011; 9: 183–194.

100.

Sexton

Baker

Nakagawa

et al.

How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men?

J Fam Pract 2013; 62: 70–78.

101.

Sexton

Baker

Perkins

et al.

Self-administered Neisseria gonorrhoeae and Chlamydia trachomatis testing in the pharynx and rectum among men who have sex with men in Washington, DC. Sex Transm Infect 2011; 87: A74–AA5.

102.

Alexander

Ison

Parry

et al.

Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men. Sex Transm Infect 2008; 84: 488–492.

103.

Holland-Hall

Wiesenfeld

Murray

. Self-collected vaginal swabs for the detection of multiple sexually transmitted infections in adolescent girls. J Pediatr Adolesc Gynecol 2002; 15: 307–313.

104.

Fang

Husman

DeSilva

et al.

Evaluation of self-collected vaginal swab, first void urine, and endocervical swab specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent females. J Pediatr Adolesc Gynecol 2008; 21: 355–360.

105.

Schachter

Chernesky

Willis

et al.

Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005; 32: 725–728.

106.

Chernesky

Hook

3rd Martin

et al.

Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis 2005; 32: 729–733.

107.

Hobbs

van der Pol

Totten

et al.

From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis 2008; 35: 8–13.

108.

Gaydos

Farshy

Barnes

et al.

Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests?

Diagn Microbiol Infect Dis 2012; 73: 16–20.

109.

Fitzhugh

Heller

. Significance of a diagnosis of microorganisms on pap smear. J Low Genit Tract Dis 2008; 12: 40–51.

110.

Chernesky

Jang

Portillo

et al.

Detection of Chlamydia trachomatis in SurePath™ liquid-based Pap samples using Aptima Combo 2™, AMPLICOR™ and ProbeTec™ assays. Can J Infect Dis Med Microbiol 2010; 21: 10A.

111.

Pittaras

Papaparaskevas

. Comparison of penile skin swab with intra-urethral swab and first void urine for polymerase chain reaction-based diagnosis of Chlamydia trachomatis urethritis in male patients. Sex Transm Dis 2008; 35: 999–1001.

112.

Jebakumar

Storey

Lusher

et al.

Value of screening for oro-pharyngeal Chlamydia trachomatis infection. J Clin Path 1995; 48: 658–661.

113.

Hammerschlag

Roblin

Gelling

et al.

Use of polymerase chain reaction for the detection of Chlamydia trachomatis in ocular and nasopharyngeal specimens from infants with conjunctivitis. Pediatr Infect Dis J 1997; 16: 293–297.

114.

Ota

Tamari

Smieja

et al.

Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture. Sex Transm Infect 2009; 85: 182–186.

115.

Peters

RPH

Verweij

Nijsten

et al.

Evaluation of sexual history-based screening of anatomic sites for Chlamydia trachomatis and Neisseria gonorrhoeae infection in men having sex with men in routine practice. BMC Infect Dis 2011; 11: 203. .

116.

Tipple

Hill

Smith

. Is screening for pharyngeal Chlamydia trachomatis warranted in high-risk groups? Int J STD AIDS 2010; 21: 770–771.

117.

Marcus

Bernstein

Kohn

et al.

Infections missed by urethral-only screening for Chlamydia or Gonorrhea detection among men who have sex with men. Sex Transm Dis 2011; 38: 922–924.

118.

Schachter

Moncada

Liska

et al.

Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008; 35: 637–642.

119.

Alexander

Martin

Ison

. Confirming the Chlamydia trachomatis status of referred rectal specimens. Sex Transm Infect 2007; 83: 327–329.

120.

Mimiaga

Mayer

Reisner

et al.

Asymptomatic gonorrhea and chlamydial infections detected by nucleic acid amplification tests among Boston area men who have sex with men. Sex Transm Dis 2008; 35: 495–498.

121.

Bachmann

Johnson

Cheng

et al.

Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol 2010; 48: 1827–1832.

122.

Ward

de Vries

HJC

van de Laar

. Re-emergence of lymphogranuloma venereum in Europe and the public health response. Sex Transm Infect 2011; 87: A19–A20.

123.

Ward

Martin

Macdonald

et al.

Lymphogranuloma venereum in the United Kingdom. Clin Infect Dis 2007; 44: 26–32.

124.

de Vries

Zingoni

White

et al.

2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. Int J STD AIDS 2013; 25: 465–474.

125.

Gdoura

Kchaou

Ammar-Keskes

et al.

Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples. J Androl 2008; 29: 198–206.

126.

Hamdad-Daoudi

Petit

. Assessment of Chlamydia trachomatis infection in asymptomatic male partners of infertile couples. J Med Microbiol 2004; 53: 985–990.

127.

Pannekoek

Westenberg

Eijk

et al.

Assessment of Chlamydia trachomatis infection of semen specimens by ligase chain reaction. J Med Microbiol 2003; 52: 777–779.

128.

van der Snoek

Ossewaarde

van der Meijden

et al.

The use of serological titres of IgA and IgG in (early) discrimination between rectal infection with non-lymphogranuloma venereum and lymphogranuloma venereum serovars of Chlamydia trachomatis. Sex Transm Infect 2007; 83: 330–334.

129.

de Vries

Smelov

Ouburg

et al.

Anal lymphogranuloma venereum infection screening with IgA anti-Chlamydia trachomatis-specific major outer membrane protein serology. Sex Transm Dis 2010; 37: 789–795.

130.

Verweij

Lanjouw

Bax

et al.

Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections. BMC Infect Dis 2014; 14: 3.

131.

Gijsen

Land

Goossens

et al.

Chlamydia antibody testing in screening for tubal factor subfertility: the significance of IgG antibody decline over time. Hum Reprod 2002; 17: 699–703.

132.

Black

. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10: 160–184.

133.

She

Welch

Wilson

et al.

Correlation of Chlamydia and Chlamydophila spp. IgG and IgM antibodies by microimmunofluorescence with antigen detection methods. J Clin Lab Anal 2011; 25: 305–308.

134.

Clad

Freidank

Kunze

et al.

Detection of seroconversion and persistence of Chlamydia trachomatis antibodies in five different serological tests. Eur J Clin Microbiol Infect Dis 2000; 19: 932–937.

135.

Mouton

Peeters

van Rijssort-Vos

et al.

Tubal factor pathology caused by Chlamydia trachomatis: the role of serology. Int J STD AIDS 2002; 13: 26–29.

136.

Verkooyen

Peeters

van Rijsoort-Vos

et al.

Sensitivity and specificity of three new commercially available Chlamydia trachomatis tests. Int J STD AIDS 2002; 13: 23–25.

137.

Land

Evers

. Chlamydia infection and subfertility. Best Pract Res Clin Obstet Gynaecol 2002; 16: 901–912.

138.

Lanjouw

Ossewaarde

Stary

et al.

2010 European guideline for the management of Chlamydia trachomatis infections. Int J STD AIDS 2010; 21: 729–737.

139.

Ministry of Health, Wellington, New Zealand. Chlamydia Management Guidelines 2008, https://www.health.govt.nz/system/files/documents/publications/chlamydia-management-guidelines.pdf (2008, accessed 15 August 2015).

140.

Fung

Scott

Kent

et al.

Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007; 83: 304–309.

141.

Scottish Intercollegiate Guidelines Network (SIGN). Management of genital Chlamydia trachomatis infection. A national clinical guideline, http://www.sign.ac.uk/pdf/sign109.pdf (2009, accessed 15 August 2015).

142.

Public Health Agency of Canada. Canadian Guidelines on sexually transmitted infection, http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/index-eng.php (accessed 15 August 2015).

143.

Health Protection Agency. National Chlamydia Screening Programme (2010), UK: National Chlamydia Screening Programme, 2010.

144.

Hosenfeld

Workowski

Berman

et al.

Repeat infection with chlamydia and gonorrhea among females: A systematic review of the literature. Sex Transm Dis 2009; 36: 478–489.

145.

Royal Australian College of General Practitioners. Guidelines for Preventive Activities in General Practice, 8th ed. http://www.racgp.org.au/download/Documents/Guidelines/Redbook8/redbook8.pdf (accessed 15 August 2015).

146.

Public Health England. National Chlamydia screening programme, http://www.chlamydiascreening.nhs.uk/ps/news.asp (accessed 15 August 2015).

147.

van de Laar

Fontaine

. ECDC guidance on chlamydia control in Europe: next steps. Euro Surveill 2009; 14: pii: 19260. .

148.

Regan

Wilson

Hocking

. Coverage is the key for effective screening of Chlamydia trachomatis in Australia. J Infect Dis 2008; 198: 349–358.

149.

Glasser

Owusu-Edusei

Glick

et al.

Controlling chlamydia: population modeling to assess promising interventions. Sex Transm Infect 2013; 89: A57.

150.

Althaus

Heijne

Herzog

et al.

Individual and population level effects of partner notification for Chlamydia trachomatis. PLoS ONE 2012; 7: e51438.

151.

Jamil

Bauer

Hocking

et al.

Chlamydia screening strategies and outcomes in educational settings: A systematic review. Sex Transm Dis 2014; 41: 180–187.

152.

Scholes

Stergachis

Heidrich

et al.

Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. New Engl J Med 1996; 334: 1362–1366.

153.

Ostergaard

Andersen

Moller

et al.

Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis 2000; 31: 951–957.

154.

Andersen

van Valkengoed

Sokolowski

et al.

Impact of intensified testing for urogenital Chlamydia trachomatis infections: a randomised study with 9-year follow-up. Sex Transm Infect 2011; 87: 156–161.

155.

Heijne

Herzog

Althaus

et al.

Insights into the timing of repeated testing after treatment for Chlamydia trachomatis: data and modelling study. Sex Transm Infect 2013; 89: 57–62.

156.

Aghaizu

Reid

Kerry

et al.

Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study. Sex Transm Infect 2014; 90: 524–528.

157.

British Association for Sexual Health and HIV. Chlamydia trachomatis UK testing guidelines. 2010. http://www.bashh.org/documents/3352.pdf (accessed 15 August 2015).

158.

Scott Lamontagne

Baster

Emmett

et al.

Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect 2007; 83: 292–303.

159.

Public Health England. 2013. Position Statement. NCSP Recommended Case Management Change: Routine offer of re-test to young adults testing positive for chlamydia, http://www.chlamydiascreening.nhs.uk/ps/resources/re-testing/NCSP%20Position%20Statement_e-testing%20of%20Positive%20Chlamydia%20Cases_August%202013_FINAL.pdf (accessed 15 August 2015).

160.

British Association of Sexual Health and HIV. 2014 Draft UK national guideline for the management of genital infection with Chlamydia trachomatis, http://www.bashh.org/BASHH/Guidelines/Guidelines/BASHH/Guidelines/Guidelines.aspx?hkey=072c83ed-0e9b-44b2-a989-7c84e4fbd9de (2013, accessed 15 August 2015).

161.

Horner

. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sex Transm Infect 2012; 88: 154–156.

162.

Sandoz

Rockey

. Antibiotic resistance in Chlamydiae. Future Microbiol 2010; 5: 1427–1442.

163.

Wang

Papp

Stamm

Peeling

Martin

Holmes

. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis 2005; 191: 917–923.

164.

O'Neill

Seth-Smith

Van Der Pol

et al.

Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes. Microbiology 2013; 159: 748–756.

165.

Handsfield

. Questioning azithromycin for chlamydial infection. Sex Transm Dis 2011; 38: 1028–1029.

166.

Schwebke

Rompalo

Taylor

et al.

Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis 2011; 52: 163–170.

167.

Sena

Lensing

Rompalo

et al.

Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis 2012; 206: 357–365.

168.

Kong

Hocking

. Treatment challenges for urogenital and anorectal Chlamydia trachomatis. BMC Infect Dis 2015; 15: 293.

169.

Somani

Bhullar

Workowski

et al.

Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181: 1421–1427.

170.

Bhengraj

Srivastava

Mittal

. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin. Int J Antimicrob Agent 2011; 38: 178–179.

171.

Mpiga

Ravaoarinoro

. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937). Int J Antimicrob Agent 2006; 27: 316–324.

172.

Amsden

. Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther 1996; 18: 56–72. discussion 55.

173.

Lode

Borner

Koeppe

et al.

Azithromycin--review of key chemical, pharmacokinetic and microbiological features. J Antimicrob Chemother 1996; 37: 1–8.

174.

Bjornelius

Anagrius

Bojs

et al.

Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008; 84: 72–76.

175.

Anagrius

Lore

Jensen

. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PloS One 2013; 8: e61481.

176.

Horner

Blee

Adams

. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!. Curr Opin Infect Dis 2014; 27: 68–74.

177.

Taylor-Robinson

Jensen

. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev 2011; 24: 498–514.

178.

Unemo

Endre

KMA

Moi

. Five-day azithromycin treatment regimen for Mycoplasma genitalium infection also effectively eradicates Chlamydia trachomatis. Acta Derm Venereol 2015. 95: 730--732.

179.

Kong

Tabrizi

Law

et al.

Azithromycin versus doxycycline for the treatment of genital Chlamydia infection: A meta-analysis of randomized controlled trials. Clin Infect Dis 2014; 59: 193–205.

180.

Ibsen

Moller

Halkier-Sorensen

et al.

Treatment of nongonococcal urethritis: comparison of ofloxacin and erythromycin. Sex Transm Dis 1989; 16: 32–35.

181.

Maiti

Chowdhury

Richmond

et al.

Ofloxacin in the treatment of uncomplicated gonorrhea and chlamydial genital infection. Clin Ther 1991; 13: 441–447.

182.

Takahashi

Ichihara

Hashimoto

et al.

Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother 2011; 17: 392–396.

183.

Cramers

Kaspersen

From

et al.

Pivampicillin compared with erythromycin for treating women with genital Chlamydia trachomatis infection. Genitourin Med 1988; 64: 247–248.

184.

Worm

Hoff

Kroon

et al.

Roxithromycin compared with erythromycin against genitourinary chlamydial infections. Genitourin Med 1989; 65: 35–38.

185.

Khrianin

Reshetnikov

. [Is it safe to use josamycin in the obstetrics practice in Russia?]. Antibiot Khimioter 2007; 52: 32–36. [In Russian].

186.

Primiero

Caruso

Grottanelli

et al.

Josamycin in the treatment of Chlamydia trachomatis cervicitis. J Chemother 1989; 1: 909–910.

187.

Lucisano

Vitale

Cinque

et al.

Josamycin in the treatment of chlamydial genital infections in infertile women. J Chemother 1989; 1: 906–908.

188.

Steedman

McMillan

. Treatment of asymptomatic rectal Chlamydia trachomatis: Is single-dose azithromycin effective? Int J STD AIDS 2009; 20: 16–18.

189.

Elgalib

Alexander

Tong

CYW

et al.

Seven days of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection. Int J STD AIDS 2011; 22: 474–477.

190.

Hathorn

Opie

Goold

. What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women? Sex Transm Infect 2012; 88: 352–354.

191.

Khosropour

Dombrowski

Barbee

et al.

Comparing azithromycin and doxycycline for the treatment of rectal chlamydial infection: A retrospective cohort study. Sex Transm Dis 2014; 41: 79–85.

192.

Drummond

Ryder

Wand

et al.

Is azithromycin adequate treatment for asymptomatic rectal chlamydia?

Int J STD AIDS 2011; 22: 478–480.

193.

British Association for Sexual Health and HIV. UK national guideline for the management of genital tract infection with Chlamydia trachomatis. http://www.bashh.org/documents/65.pdf (2006, accessed 15 August 2015).

194.

Pitsouni

Iavazzo

Athanasiou

et al.

Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agent 2007; 30: 213–221.

195.

Rahangdale

Guerry

Bauer

et al.

An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis 2006; 33: 106–110.

196.

Sarkar

Woodland

Koren

et al.

Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18.

197.

Postema

Remeijer

van der Meijden

. Epidemiology of genital chlamydial infections in patients with chlamydial conjunctivitis: a retrospective study. Genitourin Med 1996; 72: 203–205.

198.

Sulis

Urbinati

Franzoni

et al.

Chlamydia trachomatis conjunctivitis in a male teenager: a case report. Le infezioni in medicina: rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 2014; 22: 140–143.

199.

Members AAoO-CEDP. Preferred practice pattern guidelines: conjunctivitis – limited revision, 2011 2014. .

200.

Wilson

Hogben

Malka

et al.

A randomized controlled trial for reducing risks for sexually transmitted infections through enhanced patient-based partner notification. Am J Public Health 2009; 99: S104–S110.

201.

Hogben

Kissinger

. A review of partner notification for sex partners of men infected with chlamydia. Sex Transm Dis 2008; 35: S34–S39.

202.

Tiplica GS, Evans C, Gomberg M, et al. 2013 European guidelines for the management of partners of persons with sexually transmitted infections. http://www.iusti.org/regions/europe/word_docs/17.1_European_guideline_on_PN.doc (2013, accessed 15 August 2015).

203.

McIlveen

. Review: partner notification interventions can reduce persistent or recurrent sexually transmitted infections. Evidence Based Nursing 2007; 10: 107.

204.

McClean

Carne

Sullivan

et al.

Chlamydial partner notification in the British Association for Sexual Health and HIV (BASHH) 2011 UK national audit against the BASHH Medical Foundation for AIDS and Sexual Health Sexually Transmitted Infections Management Standards. Int J STD AIDS 2012; 23: 748–752.

205.

Geisler

. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 2010; 201: S104–S113.

206.

Geisler

. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007; 44: S77–S83.

207.

Bell

Potterat

. Partner notification for sexually transmitted infections in the modern world: A practitioner perspective on challenges and opportunities. Sex Transm Infect 2011; 87: ii34–ii6.

208.

Ferreira

Young

Mathews

et al.

Strategies for partner notification for sexually transmitted infections, including HIV. [Update of Cochrane Database Syst Rev 2001; (4): CD002843; PMID: 11687164]. Cochrane Database Syst Rev 2013; 10: CD002843.

209.

Althaus

Turner

KME

Mercer

et al.

Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: Observational study, systematic reviews and mathematical modelling. Health Technol Assess 2014; 18: 1–99.

210.

Pavlin

Parker

Piggin

et al.

Better than nothing? Patient-delivered partner therapy and partner notification for chlamydia: The views of Australian general practitioners. BMC Infect Dis 2009; 10: 274. .

211.

Hogben

Kidd

Burstein

. Expedited partner therapy for sexually transmitted infections. Curr Opin Obstet Gynecol 2012; 24: 299–304.

212.

Dukers-Muijrers

Morre

Speksnijder

et al.

Chlamydia trachomatis test-of-cure cannot be based on a single highly sensitive laboratory test taken at least 3 weeks after treatment. PLoS ONE 2012; 7: e34108.

213.

Renault

Israelski

Levy

et al.

Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection. Sex Health 2011; 8: 69–73.

214.

Judlin

Liao

Liu

et al.

Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. BJOG 2010; 117: 1475–1484.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.46 MB

2015 European guideline on the management of Chlamydia trachomatis infections

Abstract

Keywords

Get full access to this article

References

Supplementary Material